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1. Introduction 
The key role of cAMP* in mediating hormonal 
stimulation of lipolysis is generally accepted [cf. 1, 2]. 
The lipolytic action of cAMP and especially of its 
dibutyryl derivative iswell documented in vitro [2, 3], 
whereas the in vivo administration of cAMP failed to 
produce any significant increase in plasma FFA in 
rabbit or rat [4], significantly decreased plasma FFA 
in dog [4] and exerted abiphasic effect on plasma 
FFA when administered toman [5]. In rats, both 
normal and alloxan diabetic, DBcAMP did not elevate 
either plasma FFA or glycerol but exerted a significant 
antilipolytic effect [6]. These results are in apparent 
contradiction with the lipolytic effects of cyclic 
nucleotides on adipose tissue lipase activity in vitro. 
Moreover, it is well known that in vivo administration 
of catecholamines, the effect of which is mediated by 
cAMP, regularly elevated not only blood glucose level 
but also plasma FFA [7]. The situation is further 
complicated by the fact that cAMP, but not DBcAMP, 
was found recently to have an antilipolytic effect in 
isolated adipocytes [8]. 
In an attempt to clarify the primary effect of cyclic 
nucleotides on adipose tissue in vivo, it was thought 
worthwhile to compare the dynamics of adipose tissue 
triglyceride lipase activity after the administration of
DBcAMP (the lipolytic action of which is in vitro not 
contested) with that of norepinephrine (a relatively 
pure ~-agonist) in the presence and absence of two 
antilipolytic agents, insulin and nicotinic acid. 
* Abbreviations: cAMP, cyclic AMP; DBcAMP, dibutyryl 
cyclic AMP; FFA, free fatty acids. 
2. Materials and methods 
Male Sprague-Dawley or Wistar rats weighing 
200-250 g fed with a standard iet were used. The 
animals were anesthesized by intraperitoneal injection 
of 0.8-1.0 ml of Numal (10% diethylaminoaUyl iso- 
propyl barbituric acid) per kg body weight. To 
minimize the endogenous epinephrine production, 
hexamethonium chloride 40 mg/kg body weight was 
included in the injection. The animals were kept under 
anesthesia for 20 min and then two 0.5 cm openings 
were made in the region of the external inguinal ring 
to facilitate access to fat pads. After a further 10 rain 
of anesthesia 15-30 mg of the control samples of 
epididymal adipose tissue were taken. The animals 
were than injected intraperitoneally with the appro- 
priate drug, DBcAMP or norepinephrine with or with- 
out insulin or nicotinic acid, and at various time inter- 
vals after the injection further samples of epididymal 
adipose tissue were taken and immediately frozen on 
dry ice. The adipose tissue samples were quickly 
weighed and homogenized in an equivalent volume of 
ice-cold buffered sucrose solution (0.25 M sucrose in 
10 mM Tris-HC1 buffer pH 7.4 containing 1mM 
EDTA) and frozen immediately by immersion of the 
test tubes in alcohol cooled with dry ice. The conditions 
of homogenization a d centrifugation f the homogen- 
ate were described elsewhere [10]. The fat cake was 
discarded and the clear 1200 g infranant was taken as 
the enzyme preparation. 
In experiments where the effect of cAMP was 
tested in vitro, the enzyme preparation was preincub- 
ated for 10 min at 30°C in the presence of the follow- 
ing complete system: 0.05 M Tris-HC1 buffer pH 7.4, 
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Fig. la. Mean change in lipase activity of adipose tissue biopsy samples from zero-time following intraperitoneal administration f 
saline (o - - -o - - -o ) ;  DBcAMP ( t - - - - t - - -e ,  25 mg/kg, • -- --, 50 mg/kg, " :, 100 mg/kg) or norepinephrine (~--®--®. 
5. #moles/kg). Vertical ines represent standard error. Substrate 2-naphthol laurate 0.5 mM. When nicotinic acid was injected in- 
stead of insulin in the dose of 100 mg/kg with DBcAMP or norepinephrine, the results did not differ significantly from those ob- 
tained with insulin. 
5 × 10 -6 M ATP, 1 mM dithiothreitol, 2 mM Mg 
acetate, 10-6 M cAMP and purified heart muscle 
protein kinase (60/ag in total volume 0.2 ml). The 
emulsion of substrate was added at the end of the pre- 
incubation in a volume of 1 ml and the incubation 
continued at 37°C for 20 min. 
Lipase activity was determined as described else- 
where [ 10] using either 2-naphthol laurate or tri-, di- 
or monoolein, trilaurin as substrate or endogenous sub- 
strate (prepared according to Vaughan et al. [11 ] ). 
The preparation of emulsions of other substrates used 
has been described previously [10]. Lipase activity 
was measured by the amount of 2-naphthol liberated 
from 2-naphthol laurate stimated by the slightly 
modified method of Nachlas and Seligman [12] or FFA 
liberated from glycerides estimated by the method of 
Duncombe [13]. Protein content was measured by the 
method of Lowry et al. [14]. 
The drugs employed in this study were:N62'-O - 
dibutyryl adenosine 3'5'-monophosphate (DBcAMP) 
as the sodium salt (Boehringer, Tutzing, Germany), 
D(-)norepinephrine (Farbwerke Hoechst AG, Frank- 
furt, Germany) and Numal (Hoffmann-La Roche). The 
substrates were from Fluka AG, Buchs, Switzerland. 
2-Naphthol laurate was 99.9% pure, the glycerides 
were purified by thin layer chromatography on silica 
gel (n-heptan-diisopropyl ether-acetic acid 6:4:0.2 
v/v/v) to yield a single spot in iodine vapour [15]. 
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Fig. lb. Mean change in lipase activity of adipose tissue biopsy samples from zero-time following intraperitoneal administration f 
insulin, 0.05 U/kg (o--o--o)  simultaneously with norepinephrine 5 pmoles/kg (®--~--®) or with DBcAMP, 25 mg/kg (e e e). 
For further explanation, see legend of fig. la. 
Protein kinase was purified from beef heart by the 
method ofMiyamoto et al. [16] through the DEAE- 
cellulose column step and stored at -70°C. Prepara- 
tions were thawed immediately prior to use. 
3. Results and discussion 
In fig. 1 the time-course of changes in lipase 
activity of adipose tissue biopsy samples is shown, 
after the i.p. injection of saline, DBcAMP or norepine- 
phrine with or without insulin. The injections of both 
lipolytic agents were followed by a significant but 
transient elevation of adipose tissue lipase activity 
(fig. la), the percentage and duration of activation 
was dependent on the dose of drug used. Insulin as 
well as nicotinic acid when injected simultaneously 
with norepinephrine inhibited its lipolytic effect, 
whereas the stimulation of adipose tissue lipase activity 
by DBcAMP failed to be influenced by any of the anti- 
lipolytic agents used. 
In these studies we measured the lipase activity of 
the enzyme preparation by the cleavageof 2-naphthol 
laurate. Cleavage of this substrate was shown to 
parallel that of purified triglycerides by the hormone- 
sensitive lipase [10] while representing a more con- 
venient measurement of lipolytic activity (2-naphthol 
laurate was split at a rate about 50 times higher than 
triolein). From the results documented in table 1 it is 
obvious that the changes in 2-naphthol laurate cleavage 
after the administration of DBcAMP or norepinephrine 
correlated well with the changes of trilaurin and 
triolein cleavage whereas the hydrolysis of mono- 
olein was not affected. 
The action of insulin or nicotinic acid, which both 
reduced the activity of norepinephrine, but not that 
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Table 1 
Lipase acitivity of homogenates of adipose tissue samples taken before the injection, at the peak effect and 30 min after the peak 
effect of DBcAMP (25 mg/kg body weight i.p.) or norepinephrine (5 ~moles/kg body weight i.p.). Comparison of different sub- 
strates (concentrations i uring maximal rates were used). 
Drug injected Substrate Lipase activity (nmoles 2-naphthol r FFA/min/mg protein) 
Before the At the peak 30 min after the 
injection of the effect peak 
respective drug 
DBcAMP 25 mg/kg 
Norepinephrine 5 ~tmoles/kg 
2-Naphthollaurate 0.5 mM 185.0 ± 14.0 425.5 -+ 31.6 +) 190.4 ± 17.1 INS 
Tri laurin40mM 8.15-+ 0.7 16.45-+ 1.1 +) 6.93-+ 0.7 NS 
Triolein 10 mM 3.55 ± 0.2 15.48 ± 1.2" 4.05 -+ 0.32 NS 
Monoolein 20mM 23.8 -+ 2.0 25.5 ± 2.4N~ 24.9 ± 1.9 NS 
Endogenoussubstrate 3.36-+ 0.3 5.6 ± 0.41 +) 2.94± 0.19NS 
2-Naphthol laurate 0.5 mM 179.5 -+ 16.1 348.7 ± 29.0 +) 190.5 ± 18.7 NS 
Tri laurin40mM 7.8 ± 0.5 14.8 ± 1.1 +) 8.4 -+ 0.7 NS 
Tr io le in l0mM 3.2 ± 0.3 6.0 -+ 0.4 +) 3.4 ± 0.25NS 
Monoolein20mM 25.6 ± 2.3 24.9 -+ 2.91~1S 26.1 ± 2.3 NS 
Endogenous substrate 4.0 ± 0.3 7.9 + 0.6 +j 3.7 ± ~0.22NS 
The values represent the mean ± S.E. from 5 experiments. Statistical significance calculated against control values (before the in- 
jection). 
+)p < 0.01. 
* p < 0 .001 .  
NS, not significant. 
of  DBcAMP (fig. lb ) ,  conf i rm that  under  these in vivo 
condi t ions  we are dealing wi th  the same phenomenon 
observed in vitro [cf. 1 ]. When samples of  adipose 
tissue were taken before the admin is t rat ion of  DBcAMP 
or norepinephr ine,  at the peak of their  effects or 
30 min later when the l ipolyt ic effect had already 
disappeared and tested for responsiveness to further  
addit ion of  cAMP, the samples taken before administra- 
Table 2 
Activation of lipase activity by cAMP in vitro in adipose tissue homogenates obtained before the injection, at the peak effect and 
30 min after the peak effect of DBcAMP (25 mg/kg body weight) or norepinephrine (5 ~moles/kg body weight). For preincuba- 
tion medium see Materials and methods. Lipase substrate was 0.5 mM 2-naphthol laurate. The results represent the mean ± S.E. 
from 6 experiments. 
Preincubation medium Lipase activity (nmoles 2-naphthol/min/mg protein) 
Tissue samples from norepinephrine 
treated rats Tissue samples from DBcAMP treated rats 
Before the At the peak 30 min after Before the At the peak 30 min after 
injection effect peak effect injection effect peak effect 
Complete system 413±35.1"  455±41.2NS 392±32.9* 389_+30.1:~ 410±39.2NS 401-+35.3" 
cAMP omitted 182-+ 16.0 479-+43.1 170± 15.2 165 ± 13.3 422± 37.5 176-+ 15.9 
Protein kinase omitted 238 -+ 21.1 +) 432 -+ 37.4 NS 222 ± 20.2 +) 221 ± 19.0 +) 413 ± 39.3NS 209-+ 18.7 NS 
Statistical significance calculated against appropriate control values (cAMP omitted). 
+)p < 0.05. 
* p < 0.01. 
~t p < 0.001. 
NS, not significant. 
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tion of drugs or after their effect had disappeared, 
both responded by an increase of lipase activity averag- 
ing 100%. The results (table 2) provide strong evidence 
that the primary action of DBcAMP as well as of 
norepinephrine consists of the stimulation of triglycer- 
ide lipase(s) in adipose tissue. The fact that Bieck et al. 
[6] obtained only slight stimulation of adipose tissue 
lipase activity at an extreme dose of DBcAMP 
(100 mg/kg body weight) may be related to the fact 
that their adipose tissue samples were taken 40 min 
after the injection of DBcAMP, that is about 30 min 
after the peak effect as observed in the experiments 
of fig. 1 a. 
It is known that DBcAMP injection results in the 
elevation of circulating insulin [18]. The fact that 
insulin administered simultaneously with DBcAMP did 
not result in the inhibition of adipose tissue lipase 
activity suggest that this hormone is not directly 
responsible for the observed ecrease in plasma FFA 
and glycerol evel following the injection of DBcAMP 
[6]. These observations are in agreement with those of 
Hepp [19] and Hall and Ball [20] who did not find any 
effect of insulin on the DBcAMP stimulated lipolysis 
in adipose tissue in vitro. Our results (fig. lb) support 
the idea that insulin physiologically acts rather on 
cAMP formation than on its further effect in lipase 
activating system. 
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